Image

Global Allergy Treatment Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • May 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Allergy Treatment Market, By Type (Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis, Others), Treatment (Anti-Allergy Drugs and Immunotherapy), Route of Administration (Oral, Inhalation, Intranasal, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029

 

Allergy Treatment Market

Market Analysis and Size

In recent years, the allergy treatment market is anticipated to grow rapidly during the forecast period. Allergies, after cancer, AIDS, and cardiovascular illnesses, are the fourth most common global pathologic condition, as per the World Health Organization (WHO). On the back of a developing interdisciplinary approach to allergy diagnosis, the allergy treatment market has grown quickly over the last few decades. Anaphylaxis is characterized by severe symptoms. Bee stings, peanuts, latex, and small molecule and immunological medicines are only a few of the many triggers. The study of allergy pathophysiology has aided in the expansion of the allergy treatment market. Increased vascular permeability, face flushing, and bronchoconstriction are all life-threatening signs.

Data Bridge Market Research analyses that the allergy treatment market was valued at USD 19.07 billion in 2021 and is expected to reach USD 31.63 billion by 2029, registering a CAGR of 6.53% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

An allergy is a condition induced by the immune system's hypersensitivity to normally harmless substances in the environment, which are referred to as allergens. Dust mites, mold, tree weed, grass pollen, milk, egg, soy, wheat, and other aeroallergens are types of allergies. These allergens can induce hay fever, allergic rhinitis, asthma, atopic dermatitis, and other allergic disease disorders. Itching in the nose, roof of mouth, throat, or eyes, as well as sneezing, stuffy nose (congestion), teary eyes, and other symptoms, are all common indications of allergic reactions. Furthermore, food allergies can result in symptoms such as vomiting, diarrhea, or respiratory problems when an allergen is consumed.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Eye Allergy, Food Allergy, Skin Allergy, Asthma, Rhinitis, Others), Treatment (Anti-Allergy Drugs and Immunotherapy), Route of Administration (Oral, Inhalation, Intranasal, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Akorn, Incorporated (US), Pfizer Inc. (US), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Mylan N.V. (US), Teva Pharmaceutical Industries Ltd.(Israel), Sanofi (France), Boehringer Ingelheim International GmbH. (Germany), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Bayer AG (Germany), Merck & Co., Inc. (US),  Prestige Consumer Healthcare Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb Company (US), Almirall, S.A (Spain), Zenomed Healthcare Private Limited (India), Cadila Pharmaceuticals (India), Astellas Pharma Inc. (Japan), Eli Lilly and Company (US)

Market Opportunities

 

  • Increase in the number of emerging markets
  • Increase in the number of research and development activities
  • Rising investment for the development of advanced technologies
  • Surging drug approvals and launches

Allergy Treatment Market Dynamics

Drivers

  • Increasing prevalence of various forms of allergies

The rising prevalence of various forms of allergies is estimated to enhance the market's growth. According to a research published in 2020 by the Food Allergy Research and Education Foundation, 32 million Americans were suffered from food allergies, including 5.6 million children under the age of 18. Approximately 40% of children with food allergies are allergic to many foods.

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of allergy treatment market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

  • Growing number of geriatric population

The surging geriatric population is estimated to enhance the market's expansion during the forecast period of 2022-2029. According to the World Health Organization (WHO), the worldwide geriatric population, which was estimated to be over 524 million in 2010, is expected to increase to nearly 2 billion by 2050. Due to their compromised immune systems, geriatrics are more susceptible to get types of allergies, further estimated to enhance the market’s growth rate.

  • Surging incidences of asthma

The growing incidences of asthma is estimated to propel the market’s growth rate during the forecast period pf 2022-2029. Asthma and dietary allergies frequently coexist. Both food allergy and asthma symptoms are more likely to be severe when this happens.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the allergy treatment market. Additionally, changing lifestyle of people and growing investment by manufacturers on the development of novel allergic treatments will result in the expansion of allergy treatment market.

Opportunities

  • Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the allergy treatment market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate. 

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the allergy treatment market growth during the forecast period.

Restraints/Challenges

On the other hand, high cost associated with the treatment will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the allergy treatment market. Additionally, rising use of low cost bio-similar and lack of awareness among people about allergy immunotherapy will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This allergy treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the allergy treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Allergy treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Allergy Treatment Market

Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in a number of nations had imposed nationwide lockdowns in order to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The allergy treatment market was hampered by the supply chain slowness.

Recent Development

  • In July 2020, the Alcon had announced the U.S. Food and Drug Administration (FDA) approval of the OTC switch of Pataday once daily relief extra strength. Pataday Once Daily Comfort Extra Strength (olopatadine 0.7%) is the first and only eye allergy itch drop available in the United States that provides full 24-hour relief without a prescription.

Global Allergy Treatment Market Scope

The allergy treatment market is segmented on the basis of type, treatment, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Eye Allergy
  • Food Allergy
  • Skin Allergy
  • Asthma
  • Rhinitis
  • Others

Treatment

  • Anti-Allergy Drugs
  • Immunotherapy

Route of Administration

  • Oral
  • Inhalation
  • Intranasal
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Allergy Treatment Market Regional Analysis/Insights

The allergy treatment market is analysed and market size insights and trends are provided by country, type, treatment, route of administration, end-users and distribution channel as referenced above.

The countries covered in the allergy treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the allergy treatment market because of the rising number of research activities in this region. Additionally, rising healthcare expenditure and presence of major key players will further propel the market’s growth rate in this region.

Asia-Pacific are expected to grow during the forecast period due to increasing awareness about the diseases in this region. Also, development of healthcare infrastructure and rising level of disposable income will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Allergy Treatment Market Share Analysis

The allergy treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to allergy treatment market.

Some of the major players operating in the allergy treatment market are:

  • Akorn, Incorporated (US)
  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Boehringer Ingelheim International GmbH. (Germany)
  • AstraZeneca (UK)
  • Johnson & Johnson Private Limited (US)
  • Bayer AG (Germany)
  • Merck & Co., Inc. (US)
  • Prestige Consumer Healthcare Inc. (US)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Bristol-Myers Squibb Company (US)
  • Almirall, S.A (Spain)
  • Zenomed Healthcare Private Limited (India)
  • Cadila Pharmaceuticals (India) 
  • Astellas Pharma Inc. (Japan)
  • Eli Lilly and Company (US)

Research Methodology: Global Allergy Treatment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The market value for Allergy Treatment Market is expected USD 31.63 billion by 2029.
The Allergy Treatment Market is to grow at a CAGR of 6.53% during the forecast period of 2022 to 2029
The major players covered in the allergy treatment market are Sanofi, Johnson & Johnson Services Inc, Novartis AG, Cipla Inc, Aurobindo Pharma, Zydus Cadila, Lupin, Mylan N.V., Teva Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Amneal Pharmaceuticals PLC, Hikma Pharmaceuticals plc, GlaxoSmithKline plc and others.
Asia-Pacific is emerged as the second growing regional segment in terms of revenue due to the increase awareness about the diseases and rapidly disposable income.